ロード中...
Targeting hedgehog signaling in myelofibrosis and other hematologic malignancies
Treatment of myelofibrosis (MF), a BCR-ABL–negative myeloproliferative neoplasm, is challenging. The only current potentially curative option, allogeneic hematopoietic stem cell transplant, is recommended for few patients. The remaining patients are treated with palliative therapies to manage MF-rel...
保存先:
| 主要な著者: | , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2014
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3975838/ https://ncbi.nlm.nih.gov/pubmed/24598114 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1756-8722-7-18 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|